Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

NSAID prescribing - in need of treatment?


W ith the clinical knowledge available to them, clinicians can have a significant impact on the resources used to fund NSAID treatment and on the incidence of adverse reactions. Regrettably, clinical behaviour in the field of NSAID use continues, in many instances, to be inappropriate, damaging to patients and very expensive, according to Professor Alan Maynard, Director of the Centre of Health Economics at York University, UK. He tackled these issues, highlighting the various options available for improving the cost effectiveness of NSAID therapy, at the 10th World Congress of Gastroenterology [Los Angeles, USA; October 1994].

This is a preview of subscription content, log in to check access.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Langsdale, T., Stather, R. NSAID prescribing - in need of treatment?. Pharmacoecon. Outcomes News 18, 8–9 (1994).

Download citation


  • Ibuprofen
  • 10th World
  • Clinical Knowledge
  • Nsaid Therapy
  • Gastric Damage